Biotech

All Articles

Gene editor Volume giving up 131 laborers

.Merely times after gene publisher Volume Biosciences revealed unrevealed operational slices, a more...

Repare lays off 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is laying off a fourth of its own staff as the oncology biotech downsize its own precl...

J &amp J apply for FDA authorization of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken an additional step toward understanding a yield on its $6.5 billion ...

Gain's phase 1 gain paves means to verify Parkinson's medication's worth

.Gain Rehabs has established its sights on verifying the efficiency of its Parkinson's illness thera...

Actinogen reports brand-new phase 2 information to recover depression drug

.Actinogen Medical's hopes-- and also stock cost-- have rebounded somewhat from earlier this month, ...

Pfizer and also Flagship add Ratio to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have actually added Quotient right into their 10-program relatio...

Bayer pens $547M contract to press limits of noncoding RNA

.Bayer managers were actually interested to tension to Fierce this summertime that the German pharma...

UK unveils strategies to launch 18 brand-new clinical test hubs

.In the middle of a yearslong medical trial downtrend in the U.K., a brand-new public-private allian...

UPDATE: Genentech telegraphs 93 cutbacks in The golden state after sharing plans to shutter cancer cells immunology study unit

.Adhering to the statement of a sizable unemployment round in April and also a significant rebuildin...

Neurocrine's KarXT rival reaches in period 2-- but only at low dosage

.Neurocrine Biosciences has actually achieved its own hoped-for account in a period 2 schizophrenia ...